RSS

bioconjugation services

Biotechnology company, ADC Biotechnology, has announced that it is developing a new ‘downstream bioconjugation’ method that will enable conjugation and antibody purification to be performed concurrently. more

News

A partnership agreement has been signed by specialist antibody drug conjugate (ADC) contract services company, ADC Biotechnology, and multi-disciplined engineering specialists, WHP, for construction of a dedicated bioconjugation facility. more

News

ADC Biotechnology has secured investment for an $11 million bioconjugation facility, to be constructed at its new site in Deeside, North Wales, UK. more

News

A fully integrated antibody drug conjugate (ADC) facility is to be built at Novasep's Le Mans site in France, complementing the company's current ADC offering with full bioconjugation services to meet increasing market demand. more

News